Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginesatide for Anemia in Peritoneal Dialysis
NCT00752791Phase 2Completed
- Sponsor
- Takeda
- Start
- Oct 2008
- Primary completion
- May 2010
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 5
01
Overview
A Phase 2 trial of peginesatide in anemia of chronic kidney disease (CKD-A), sponsored by Takeda. Started Oct 2008; status: completed.
02
Drugs
peginesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00752791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752791.